Year: 2026
Type: article
Abstract: The prevalence of obesity continues to rise steadily. Obesity is a well-established leading risk factor for type 2 diabetes and cardiovascular diseases. However, iron deficiency (ID) and iron deficiency anemia (IDA) are far less frequently discussed in the context of obesity-related complications. In obesity, chronic systemic inflammation develops, increasing the production of pro-inflammatory cytokines. This leads to elevated hepcidin levels - a protein that suppresses iron absorption by blocking ferroportin in the duodenum. Among individuals with overweight and obesity, lower serum iron, ferritin, and hemoglobin levels are observed compared to those with normal body weight. Bariatric surgical interventions, aimed at radical obesity treatment, reduce body weight and suppress systemic inflammation. Yet, they simultaneously impair iron absorption due to duodenal bypass, intestinal villous atrophy, and hypochlorhydria, which blocks the conversion of Fe 3+ to bioavailable Fe 2+ , thereby exacerbating iron deficiency. Correction of ID and IDA in obese patients requires a comprehensive approach, including regular monitoring of iron metabolism markers, a diet emphasizing heme iron and vitamin C, and iron supplementation therapy.
Institution: Samara State Medical University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7236310982
